Showing results (881-890 of 2,180) with videos related to
Sort By:
Pageof 218
Journal of Biopharmaceutical Statistics|December 15, 2022
Real world data (RWD) in pediatricsTamar Lasky, Aloka ChakravartyJournal of Biopharmaceutical Statistics|December 9, 2022
Equivalence tests before end of follow-up under the class of log transformation modelPao-Sheng ShenJournal of Biopharmaceutical Statistics|December 13, 2022
Parameter estimation of Weibull distribution for the number of days between drug administration and early onset adverse eventToru Ogura, Chihiro ShiraishiJournal of Biopharmaceutical Statistics|June 8, 2022
Propensity score-integrated approach to survival analysis: leveraging external evidence in single-arm studiesWei-Chen Chen, Nelson Lu, Chenguang Wang, et al.Journal of Biopharmaceutical Statistics|June 8, 2022
Statistical methods of indirect comparison with real-world data for survival endpoint under non-proportional hazardsZihan Lin, Dan Zhao, Junjing Lin, et al.Journal of Biopharmaceutical Statistics|June 9, 2022
A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical dataWen Zhang, Zhiying Pan, Ying YuanJournal of Biopharmaceutical Statistics|June 30, 2022
Statistical learning in preclinical drug proarrhythmic assessmentNan Miles Xi, Yu-Yi Hsu, Qianyu Dang, et al.Journal of Biopharmaceutical Statistics|May 31, 2021
A Cholesky-based sparse covariance estimation with an application to genes dataChunshi Li, Mo Yang, Mingqiu Wang, et al.Journal of Biopharmaceutical Statistics|September 21, 2020
TEPI-2 and UBI: designs for optimal immuno-oncology and cell therapy dose finding with toxicity and efficacyPin Li, Rachael Liu, Jianchang Lin, et al.Journal of Biopharmaceutical Statistics|December 7, 2020
Bayesian joint modeling for partially linear mixed-effects quantile regression of longitudinal and time-to-event data with limit of detection, covariate measurement errors and skewnessHanze Zhang, Yangxin HuangPageof 218